What is the nature of the 1,628-share EMN award to James J. O'Brien?

The 1,628-share award is described as the director’s annual Restricted Stock Award. It is a grant of common stock at a recorded price of $0.0000 per share, reflecting a compensation grant rather than a market transaction or cash-based share purchase.

Eastman Chemical (EMN) director receives 1,628-share restricted award

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

OBRIEN JAMES J /KY reported acquisition or exercise transactions in this Form 4 filing.

Eastman Chemical director James J. O'Brien received a grant of 1,628 shares of common stock as a restricted stock award. The award was granted at no cash cost and represents his annual Restricted Stock Award. After this grant, he holds 8,456 shares directly.

The restricted shares are scheduled to lapse on May 7, 2027, subject to conditions tied to his continued service as a director. In addition to his direct holdings, he also indirectly owns 1,022 shares through a revocable trust.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider OBRIEN JAMES J /KY

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,628	$0.00	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 8,456 shares (Direct, null); Common Stock — 1,022 shares (Indirect, By Revocable Trust)

Footnotes (1)

[object Object]

Key Figures

Restricted stock grant: 1,628 shares Direct holdings after grant: 8,456 shares Indirect holdings via trust: 1,022 shares +2 more

5 metrics

Restricted stock grant 1,628 shares Annual Restricted Stock Award on common stock

Direct holdings after grant 8,456 shares Common stock held directly following award

Indirect holdings via trust 1,022 shares Common stock held indirectly by revocable trust

Restricted shares lapse date May 7, 2027 Restrictions lapse subject to continued service as director

Recorded grant price $0.0000 per share Compensation grant, not open-market purchase

Key Terms

Restricted Stock Award, Restricted shares, Revocable Trust, Grant, award, or other acquisition

4 terms

Restricted Stock Award financial

"The shares amounts represent the director's annual Restricted Stock Award."

A restricted stock award is company shares given to an employee or executive that cannot be sold or fully owned until certain conditions—like staying with the company for a set time or hitting performance targets—are met. Think of it as a gift that only becomes yours after you fulfill specific obligations; for investors, these awards matter because they can increase the total shares outstanding when they vest, reveal how management is being paid and motivated, and create potential selling pressure when restrictions lift.

Restricted shares financial

"Restricted shares, with restrictions lapsing on May 7, 2027, subject to certain conditions"

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

Revocable Trust financial

"direct_or_indirect: "I", nature_of_ownership: "By Revocable Trust""

A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.

Grant, award, or other acquisition financial

"transaction_code_description: "Grant, award, or other acquisition""

Form 4 Insider Transactions: What Each Field Means →

05/11/2026 - 04:08 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

OBRIEN JAMES J /KY

(Last)

(First)

(Middle)

200 S. WILCOX DRIVE

(Street)

KINGSPORT

TENNESSEE

37660

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
EASTMAN CHEMICAL CO [ EMN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/07/2026		A		1,628⁽¹⁾	A	$0	8,456	D
Common Stock								1,022	I	By Revocable Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Restricted shares, with restrictions lapsing on May 7, 2027, subject to certain conditions related to continued service as a director. The shares amounts represent the director's annual Restricted Stock Award.

Remarks:

	/s/ Mark D. Austin, by Power of Attorney for James J. O'Brien	05/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did EMN director James J. O'Brien report?

James J. O'Brien reported receiving 1,628 shares of Eastman Chemical common stock as a restricted stock award. This is a compensation-related grant at no cash cost, not an open-market purchase or sale, and increases his direct equity stake in the company.

How many Eastman Chemical (EMN) shares does James J. O'Brien now hold?

After the latest restricted stock grant, James J. O'Brien directly holds 8,456 Eastman Chemical shares. He also indirectly owns 1,022 shares through a revocable trust, giving him both direct and indirect exposure to the company’s common stock.

When do James J. O'Brien’s newly granted EMN restricted shares vest?

The 1,628 restricted shares granted to James J. O'Brien are scheduled to lapse on May 7, 2027. Vesting is conditioned on certain requirements, including continued service as a director, aligning the award with long-term board tenure and oversight.

Does James J. O'Brien hold any Eastman Chemical shares indirectly?

Yes. In addition to his directly held shares, James J. O'Brien has 1,022 Eastman Chemical shares reported as indirectly owned through a revocable trust. This indicates part of his stake is structured via a trust-related ownership arrangement.